Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia

References

• ComellaCLJankovicJTruongDDHanschmannAGrafeSU.S. Xeomin Cervical Dystonia Study Group. Efficacy and safety of incobotulinumtoxinA (NT, 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystoniaJ Neurol Sci20113081–210310921764407
   PubMed Web of Science ®Google Scholar
• TruongDDuaneDDJankovicJEfficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled studyMov Disord200520778379115736159
   PubMed Web of Science ®Google Scholar
• CostaJEspirito-SantoCBorgesABotulinum type B for cervical dystoniaCochrane Database Syst Rev2005251CD004315
   Google Scholar
• MillsRRPaganFLPatient considerations in the treatment of cervical dystonia: focus on botulinum type APatient Pref Adherence20159725731
   Web of Science ®Google Scholar
• SimpsonDMBlitzerABrashearAAssessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)Neurology2008701916901706
   Web of Science ®Google Scholar
• MordinMMasaquelCAbbottCMerrimanCCFactors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with botulinumtoxin A (Dysport): results from a randomised, double-blind, placebo-controlled studyBMJ20144e005150
   PubMed Web of Science ®Google Scholar
• SlawekJFriedmanAPotulskaAFactors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injectionsFunct Neurol20072229510017637212
   PubMed Web of Science ®Google Scholar
• AlbaneseAAbbruzzeseGDresslerDPractical guidance for CD management involving treatment of botulinum toxin: a consensus statementJ Neurol2015262102201221325877834
   PubMed Web of Science ®Google Scholar
• FernandezHPaganFDanisiFProspective study evaluating incobotulinumtoxinA for cervical dystonia or blepharospasm: interim results from the first 145 subjects with cervical dystoniaTremor Other Hyperkinetic Mov (N Y)20133
   Google Scholar
• HilkerRScgischniaschviliMGhaemiMJacobsARudolfJHealth related quality of life is improved bybotulinum neurotoxin type A in long term treated patients with focal dystoniaJ Neurol Neurosurg Psychiatry200171219319911459891
   PubMed Web of Science ®Google Scholar
• SkogseidIMMaltUFRøislienJKertyEDeterminants and status of quality of life after long-term botulinum therapy for cervical dystoniaEurop J Neurol2007141011291137
   Web of Science ®Google Scholar
• ConteABerardelliIFerrazzanoGPasquiniMBerardelliAFabbriniGNon-motor symptoms in patients with adult-onset focal dystonia: sensory and psychiatric disturbancesParkinsonism Relat Disord201622Suppl 1S111S11426360238
   PubMed Web of Science ®Google Scholar
• FabbriniGBerardelliIMorettiGPsychiatric disorders in adult-onset focal dystonia: a case-controlled studyMov Disord201025445946520108377
   PubMed Web of Science ®Google Scholar
• HallTAMcGwinGSearceyKHealth-related quality of life and psychosocial characteristics of patients with benign essential blepharospasmArch Ophthalmol2006124111611916401794
   PubMedGoogle Scholar
• LencerRSteinlechnerSStahlbergJPrimary focal dystonia: evidence for distinct neuropsychiatric and personality profilesJ Neurol Neurosurg Psychiatry200980101176117919465414
   PubMed Web of Science ®Google Scholar
• MoraruESchniderPWimmerARelation between depression and anxiety in dystonic patients: implications for clinical managementDepression Anxiety200216310011312415533
   PubMed Web of Science ®Google Scholar
• MüllerJKemmlerGWisselJThe impact of blepharospasm and cervical dystonia on health related quality of life and depressionJ Neurol2002249784284612140667
   PubMed Web of Science ®Google Scholar
• PageDButlerAJahanshahiMQuality of life in focal, segmental, and generalized dystoniaMov Disord200722334134717216640
   PubMed Web of Science ®Google Scholar
• TomicSPetkovicIPucicTResanBJuricSRotimTCervical dystonia and quality of lifeActa Neurol Belg2016116458959227138215
   PubMed Web of Science ®Google Scholar
• PekmezovicTSvetelMIvanovicNQuality of life in patients with focal dystoniaClin Neurol Neurosurg2009111216116418995953
   PubMed Web of Science ®Google Scholar
• GündelHWolfAXidaraVBuschRCeballos-BaumannAOSocial phobia in spasmodic torticollisJ Neurol Neurosurg Psychiatry200171449950411561034
   PubMed Web of Science ®Google Scholar
• Ozel-KizilETAkbostanciMCOzguvenHDAtbasogluECSecondary social anxiety in hyperkinesiaMov Disord200823564164518220295
   PubMed Web of Science ®Google Scholar
• HallettMAlbaneseADresslerDEvidence-based review and assessment of botulinum neurotoxin for the treatment of movement disordersToxicon2013679411423380701
   PubMed Web of Science ®Google Scholar
• WerleRWTakedaSYZontaMBGuimarãesATTeiveHAThe physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystoniaArq Neuropsiquiatr201472640541024964104
   PubMed Web of Science ®Google Scholar
• HefterHBeneckeRErbguthFJostWReichelGWisselJAn open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxinA (Dysport)BMJ Open201334e001853
   Web of Science ®Google Scholar
• BirnerPSchniderPMüllerJWisselJFuchsIAuffETorticollis spasmodicus, Blepharospasmus und hemifazialerSpasmus, Subjektive Bewertungen der Therapie durch Patienten. [Spasmodic torticollis, blepharospasm, and hemifacial spasm – subjective therapy evaluations by patients]Nervenarzt19997010903908 German10554782
   PubMed Web of Science ®Google Scholar
• JunkerJOberwittlerCJacksonDBergerKUtilization and perceived effectiveness of complementary and alternative medicine in patients with dystoniaMov Disord200419215816114978670
   PubMed Web of Science ®Google Scholar
• LeplowBJerschMSchönfeldRMedizinische und nicht-medizinische Begleitbehandlungenzur Botulinum-Toxin-Therapie bei Torticollisspasmodicus Patienten. [Botulinum toxin therapy for spasmodic torticollis – medical and non-medical adjunct treatments]Nervenarzt201384493497 German23371379
   PubMed Web of Science ®Google Scholar
• LeplowBWiemannJZwischen disability und handicap – Zur Frage der Therapietreuevon Torticollispatienten bei der Therapie mit Botulinumtoxin. [Between disability and handicap – to the question about compliance of spasmodic torticollis patients during botulinum toxin therapy]Nervenheilkunde201028519525 German
   Google Scholar
• MeigeHFeindelEDer Tic – Sein Wesen und seine Behandlung. [The Tic – Its Nature and Treatment]1903Leipzig und WienFranz Deuticke German
   Google Scholar
• WartenbergRZur Klinik und Pathophysiologie der extrapyramidalen Bewegungsstörungen. [To the clinic and pathophysiology of extrapyramidal movement disorders]Z Neurol192384303354 German
   Google Scholar
• QuadfaselFKrayenbühlHÜber Haltungsstörungen und ihre Beeinflußbarkeit. [About posture disorders and their ability to influence]Monatsschr Psychiatr1934883986 German
   Google Scholar
• JahanshahiMFactors that ameliorate or aggravate spasmodic torticollisJ Neurol Neurosurg Psychiatry200068222722910644795
   PubMed Web of Science ®Google Scholar
• Ben-SchlomoYCamfieldLWarnerTESDE collaborative group. What are the determinants of quality of life in people with cervical dystonia?J Neurol Neurosurg Psychiatry200272560861411971047
   PubMed Web of Science ®Google Scholar
• van den DoolJTijssenMAKoelmanJHEngelbertRHVisserBDeterminants of disability in cervical dystoniaParkinsonism Relat Disord201632485327553512
   PubMed Web of Science ®Google Scholar
• CamfieldLBen-SlomoYWarnerTTEpidemiological Study of Dystonia in Europe Collaborative GroupImpact of cervical dystonia on quality of lifeMov Disord200217483884112210891
   PubMed Web of Science ®Google Scholar
• PapathanasiouIMacDonaldLWhurrRJahanshahiMPerceived stigma in spasmodic torticollisMov Disord20011628028511295781
   PubMed Web of Science ®Google Scholar
• LewisLButlerAJahanshahiMDepression in focal, segmental and generalized dystoniaJ Neurol2008255111750175519156488
   PubMed Web of Science ®Google Scholar
• JahanshahiMPsychosocial factors and depression in torticollisJ Psychosom Res1991354–54935071920180
   PubMed Web of Science ®Google Scholar
• MolhoESAgarwalNReganKHigginsDSFactorSAEffect of cervical dystonia on employment: a retrospective analysis of the ability of treatment to restore premorbid employment statusMov Disord20092491384138719441129
   PubMed Web of Science ®Google Scholar
• DresslerDTacikPAdib SaberiFBotulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxin A (Botox®) and incobotulinum-toxin A (Xeomin®)J Neural Transm (Vienna)20141211293123913131
   PubMed Web of Science ®Google Scholar
• MarshWAMonroeDMBrinMFGallagherCJSystematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystoniaBMC Neurol2014149124767576
   PubMed Web of Science ®Google Scholar
• EvidenteVGTruongDJankovicJComellaCLGrafeSHanschmannAIncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well toleratedJ Neurol Sci20143461–211612025186131
   PubMed Web of Science ®Google Scholar
• DresslerDTacikPSaberiFABotulinum toxin therapy of cervical dystonia: duration of therapeutic effectsJ Neural Transm (Vienna)2015122229730025052566
   PubMed Web of Science ®Google Scholar
• PolizianiMKochMLiuXStriving for more good days: patient perspectives on botulinum toxin for the treatment of cervical dystoniaPatient Prefer Adherence2016101601160827578965
   PubMed Web of Science ®Google Scholar
• TruongDBotulinum neurotoxin and dystonia: a case for greater flexibility in treatment regimens?CNS2017221217
   Google Scholar
• OjoOOFernandezHHIs it time for flexibility in botulinum inter-injection intervals?Toxicon2015107Pt A727626440738
   PubMed Web of Science ®Google Scholar